Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: a PROpensity ScorE Analysis of Treatment Beyond Second Line (proserpyna Study)
Clinical Colorectal Cancer（2024）
Key words
Rechallenge,Reintroduction,Regorafenib,Trifluridine/Tipiracil,Refractory
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined